
Airfinity Limited

Airfinity - Biorisk Surveillance Software
The world’s most comprehensive biorisk surveillance solution, providing real-time alerts and analysis on emerging outbreaks and infectious disease risks.
Most popular related searches
infectious disease risk
COVID 19
disease risk
COVID pandemic
COVID situation
disease surveillance
disease outbreak
The COVID-19 pandemic serves as a permanent reminder of the need for real-time infectious disease intelligence to better understand the current and future risk of different populations.
Airfinity Biorisk equips decision makers with a holistic overview of the global infectious disease risk situation, covering 160+ diseases across 180+ countries and 20+ languages
Independent risk frameworks provide multi-dimension rankings by analysing emerging outbreaks and disease dynamics, as well as a country’s ability to cope with different scenarios through medical countermeasures.
Daily Risk Alerts
A daily email alert with near real-time risk assessment of outbreaks worldwide, including any new changes in cases or any new variants detected.
A daily email alert with near real-time risk assessment of outbreaks worldwide, including any new changes in cases or any new variants detected.
24/7 Platform Access
Get access to a live Global Outbreaks Tracker, as well as real time epidemiological analysis and monitoring (including COVID-19 and Monkeypox), all with extensive filtering options and downloadable data.
Get access to a live Global Outbreaks Tracker, as well as real time epidemiological analysis and monitoring (including COVID-19 and Monkeypox), all with extensive filtering options and downloadable data.
- Airfinity Biorisk comes with two in-depth weekly intelligence reports to give decision makers a clear overview of current and upcoming threats.
- Biorisk Report: a One Health overview of current outbreaks worldwide with in the context of wider environmental changes, deep dive analysis and forecasts.
- COVID-19 Pandemic Report: detailed epidemiological analysis of the COVID-19 situation, including variant spread.